电子健康记录系统中阿片类药物默认剂量数量与青少年及年轻成人扁桃体切除术后阿片类药物处方的关联
该非随机临床试验纳入2019年10月1日至2021年7月31日在一家三级医疗中心行扁桃体切除术的12至50岁青少年及年轻成人共237例,将儿科耳鼻喉科患者的医嘱套中阿片类默认剂量从30剂降至12剂,并与普通耳鼻喉科患者对照。干预后儿科耳鼻喉科患者出院阿片处方含12剂的比例从1.4%(1/70)升至44.3%(27/61),差异变化45.5个百分点(95%CI 32.2-58.8);平均处方剂数从22.3(7.4)降至16.1(6.5),差异百分比变化-29.2%(95%CI -43.2%至-11.7%)。干预未伴随药物补充或疼痛相关就诊的变化;二次分析中除睡眠障碍评分差异增加3.5分(95%CI 1.5-5.5,评分范围4-20,分数越高睡眠越差)外,患者报告结局无变化。作者认为,基于证据的默认剂量设置可能减少围手术期阿片处方而不影响镇痛。
要点
- 在儿科耳鼻喉科扁桃体切除术医嘱套中将阿片类默认剂量从30剂降至12剂后,出院处方含12剂的比例从1.4%(1/70)升至44.3%(27/61),差异变化45.5个百分点(95%CI 32.2-58.8)。
- 同一干预使儿科耳鼻喉科患者平均处方剂数从22.3(7.4)降至16.1(6.5),差异百分比变化-29.2%(95%CI -43.2%至-11.7%)。
- 干预未伴随处方补充或术后2周内疼痛相关就诊的变化。
- 二次分析(150例)中,干预未伴随患者报告结局变化,但睡眠障碍评分差异增加3.5分(95%CI 1.5-5.5,评分范围4-20,分数越高睡眠质量越差)。
- 作者认为,基于证据的默认剂量设置可能减少青少年及年轻成人扁桃体切除术围手术期阿片处方而不影响镇痛。
适用人群与场景
- 纳入2019年10月1日至2021年7月31日在一家三级医疗中心行扁桃体切除术的12至50岁青少年及年轻成人。
- 治疗组为儿科耳鼻喉科服务患者(大多12-21岁),对照组为普通耳鼻喉科服务患者(大多18-25岁)。
处置流程与药物剂量
- 基于干预前儿科耳鼻喉科患者的阿片消耗量,将扁桃体切除术医嘱套中阿片类默认剂量数量从30剂降至12剂;该变更仅针对儿科耳鼻喉科患者。
- 术后第14天通过调查收集患者报告的阿片消耗量和结局。
研究设计与关键结果
- 研究类型为非随机临床试验,纳入237例患者(147例女性[62.0%];平均[SD]年龄17.3[3.6]岁)。
- 在131例儿科耳鼻喉科患者中,出院阿片处方含12剂的比例:干预前1/70(1.4%) vs 干预后27/61(44.3%),差异变化45.5个百分点(95%CI 32.2-58.8个百分点)。
- 儿科耳鼻喉科患者平均(SD)处方剂数:干预前22.3(7.4) vs 干预后16.1(6.5),差异百分比变化-29.2%(95%CI -43.2%至-11.7%)。
- 干预未伴随处方补充或疼痛相关就诊的变化。
- 二次分析纳入150例患者,干预未伴随患者报告结局变化,但睡眠障碍评分差异增加3.5分(95%CI 1.5-5.5分),评分范围4-20,分数越高睡眠质量越差。
证据类型、等级与局限
- 证据类型:非随机临床试验(ClinicalTrials.gov标识NCT04066829)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于证据的默认剂量设置可能减少青少年及年轻成人扁桃体切除术围手术期阿片处方,而不影响镇痛。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: In prior studies, decreasing the default number of doses in opioid prescriptions written in electronic health record systems reduced opioid prescribing. However, these studies did not rigorously assess patient-reported outcomes, and few included pediatric patients.
OBJECTIVE: To evaluate the association between decreasing the default number of doses in opioid prescriptions written in electronic health record systems and opioid prescribing and patient-reported outcomes among adolescents and young adults undergoing tonsillectomy.
DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized clinical trial included adolescents and young adults aged 12 to 50 years undergoing tonsillectomy from October 1, 2019, through July 31, 2021, at a tertiary medical center. The treatment group comprised patients from a pediatric otolaryngology service (mostly aged 12-21 years) and the control group comprised patients from a general otolaryngology service (mostly aged 18-25 years).
INTERVENTIONS: Data on patient-reported opioid consumption and outcomes were collected via a survey on postoperative day 14. Based on opioid consumption among pediatric otolaryngology patients before the intervention, the default number of opioid doses was decreased from 30 to 12 in a tonsillectomy order set. This change occurred only for pediatric otolaryngology patients.
MAIN OUTCOMES AND MEASURES: Proportion of patients with 12 doses in the discharge opioid prescription, number of doses in this prescription, and refills and pain-related visits within 2 weeks of surgery. In a secondary analysis of patients completing the postoperative survey, patient-reported opioid consumption, pain control, sleep disturbance, anxiety, and depression were assessed. Linear or log-linear difference-in-differences models were fitted, adjusting for patients' demographic characteristics and presence of a mental health or substance use disorder.
RESULTS: The study included 237 patients (147 female patients [62.0%]; mean [SD] age, 17.3 [3.6] years). Among 131 pediatric otolaryngology patients, 1 of 70 (1.4%) in the preintervention period and 27 of 61 (44.3%) in the postintervention period had 12 doses in the discharge opioid prescription (differential change, 45.5 percentage points; 95% CI, 32.2-58.8 percentage points). Among pediatric otolaryngology patients, the mean (SD) number of doses prescribed in the preintervention period was 22.3 (7.4) and in the postintervention period was 16.1 (6.5) (differential percentage change, -29.2%; 95% CI, -43.2% to -11.7%). The intervention was not associated with changes in refills or pain-related visits. The secondary analysis included 150 patients. The intervention was not associated with changes in patient-reported outcomes except for a 3.5-point (95% CI, 1.5-5.5 points) differential increase in a sleep disturbance score that ranged from 4 to 20, with higher scores indicating poorer sleep quality.
CONCLUSIONS AND RELEVANCE: This nonrandomized clinical trial suggests that evidence-based default dosing settings may decrease perioperative opioid prescribing among adolescents and young adults undergoing tonsillectomy, without compromising analgesia.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04066829.
参考来源
- Chua KP, Thorne MC, Ng S, et al. Association Between Default Number of Opioid Doses in Electronic Health Record Systems and Opioid Prescribing to Adolescents and Young Adults Undergoing Tonsillectomy. JAMA Netw Open. 2022. PMID: 35771572. doi:10.1001/jamanetworkopen.2022.19701
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。